Abstract
Transcatheter therapy of the mitral valve is more challenging compared to the aortic valve. Interventional therapy with the Mitra-Clip system, mimicking the surgical edge-to-edge repair, was first introduced in 2003 and received the CE mark in 2008. The first implantation of the Tendyne system, which is currently the only commercially available system for mitral valve replacement, was performed in 2014, and routine clinical use was approved in 2020. Several new valve platforms are in clinical development and will expand the treatment portfolio. This article will discuss the clinical indications, technical challenges and specific requirements for perioperative management.
Original language | English |
---|---|
Number of pages | 3 |
Journal | Medizinische Klinik - Intensivmedizin und Notfallmedizin |
DOIs | |
Publication status | Published - 2022 |
Fields of science
- 302081 Thoracic surgery
- 302026 Heart surgery
- 302018 Vascular surgery